Chattanooga Oncology and Hematology Associates, PC

Chattanooga, Tennessee 37404

0 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Colorectal Neoplasms, Diffuse Large B-Cell Lymphoma, Kidney Neoplasms, Non Small Cell Lung Cancer, Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Non-Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC). — Stopped early
• A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) — Stopped early
• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry) — Completed
• Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer — Stopped early
• Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients — Completed
• A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer — Completed